Reset
Showing 20 of 49 academic articles

Quantum Computing in Medicine

James C. L. Chow • Medical Sciences (2024)

Quantum computing (QC) represents a paradigm shift in computational power, offering unique capabilities for addressing complex problems that are infeasible for classical computers. This review paper provides a detailed account of the curren...

OPENALEX cc-by DOI: https://doi.org/10.3390/medsci12040067 PMC: 11586987

A Survey on Neural Network Interpretability

Yu Zhang, Peter Tiňo B, Aleš Leonardis, Ke Tang • IEEE Transactions on Emerging Topics in Computational Intelligence (2021)

Along with the great success of deep neural networks, there is also growing concern about their black-box nature. The interpretability issue affects people's trust on deep learning systems. It is also related to many ethical problems, e.g.,...

OPENALEX Open Access DOI: https://doi.org/10.1109/tetci.2021.3100641

A renaissance of neural networks in drug discovery

Igor I. Baskin, David Alan Winkler, Igor V. Tetko • Expert Opinion on Drug Discovery (2016)

INTRODUCTION: Neural networks are becoming a very popular method for solving machine learning and artificial intelligence problems. The variety of neural network types and their application to drug discovery requires expert knowledge to cho...

OPENALEX DOI: https://doi.org/10.1080/17460441.2016.1201262

Self-Normalizing Neural Networks

Günter Klambauer, Thomas Unterthiner, Andreas Mayr, Sepp Hochreiter • arXiv (Cornell University) (2017)

Deep Learning has revolutionized vision via convolutional neural networks (CNNs) and natural language processing via recurrent neural networks (RNNs). However, success stories of Deep Learning with standard feed-forward neural networks (FNN...

OPENALEX Open Access DOI: https://doi.org/10.48550/arxiv.1706.02515

Combinatorial Materials Science and Catalysis

Bernd Jandeleit, Dieter J. Schaefer, Timothy S. Powers, Howard W. Turner et al. • Angewandte Chemie International Edition (1999)

After forever changing the drug discovery process in the pharmaceutical industry, combinatorial chemistry methodologies are increasingly being applied to the discovery and optimization of more efficient catalysts and materials (see picture)...

OPENALEX DOI: https://doi.org/10.1002/(sici)1521-3773(19990903)38:17<2494::aid-anie2494>3.0.co;2-#

Quantum Computing for Healthcare: A Review

Raihan Ur Rasool, Hafiz Farooq Ahmad, Wajid Rafique, Adnan Qayyum et al. • Future Internet (2023)

In recent years, the interdisciplinary field of quantum computing has rapidly developed and garnered substantial interest from both academia and industry due to its ability to process information in fundamentally different ways, leading to ...

OPENALEX cc-by DOI: https://doi.org/10.3390/fi15030094

Coalition of explainable artificial intelligence and quantum computing in precision medicine

Soumyadeep Ray, Pronaya Bhattacharya, Ebrahim A. Mattar, Abhishek Mukhopadhyay • Computational and Structural Biotechnology Journal (2025)

This survey examines the convergence of Explainable Artificial Intelligence (XAI) and Quantum Computing (QC) toward precision medicine. We review developments from 2018 to 2025, summarizing quantum algorithms, quantum-machine-learning model...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.csbj.2025.11.031

P2′ Site Scanning of Snake Kunitz-Type Toxin Analogue BF9-N17H with Unique P1 Site Histidine Highlights Novel XIa Inhibitory Peptides Without Plasmin Inhibitory Activity

Luyao Wang, Li Ding, Tianxiang Qin, Xinyu Liu et al. • Toxins (2026)

Kunitz-type peptides from venomous and blood-sucking animals represent an important natural molecular resource for anticoagulant development towards XIa, a new target for antithrombotic drug discovery. However, the plasmin-inhibitory activi...

DOAJ Open Access (DOAJ) DOI: 10.3390/toxins18100449

Cold storage of human precision-cut lung slices in TiProtec preserves cellular composition and transcriptional responses and enables on-demand mechanistic studies

M. Camila Melo-Narvaez, Fee Gölitz, Eshita Jain, Janine Gote-Schniering et al. • Respiratory Research (2025)

Abstract Background Human precision-cut lung slices (hPCLS) are a unique platform for functional, mechanistic, and drug discovery studies in the field of respiratory research. However, tissue availability, generation, and cultivation time r...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12931-025-03132-w

Artificial Intelligence in Healthcare: Advancing Innovation and Ethics to Foster Well-Being

Bayram B., Leventi N., Vodenicharova A., Lamprianidou A. et al. • Acta Medica Bulgarica (2026)

Artificial intelligence (AI) is reshaping healthcare by enhancing diagnostic precision, treatment personalization, and overall patient care. By leveraging technologies such as machine learning, deep learning, natural language processing, an...

DOAJ Open Access (DOAJ) DOI: 10.2478/amb-2026-0050

Overview of Artificial Neural Networks

Jinming Zou, Yi Han, Sung‐Sau So • Methods in molecular biology (2008)

The artificial neural network (ANN), or simply neural network, is a machine learning method evolved from the idea of simulating the human brain. The data explosion in modem drug discovery research requires sophisticated analysis methods to ...

OPENALEX DOI: https://doi.org/10.1007/978-1-60327-101-1_2

DVNDTA: a dual virtual node based heterogeneous interaction model for accurate prediction of drug-target affinity

Guoqiang Zhou, Ben Li, Weifeng Zhang, Shudi Bao et al. • BMC Bioinformatics (2026)

Abstract Efficient prediction of drug-target affinity (DTA) is crucial for accelerating drug discovery. Recently, deep learning approaches leveraging 3D complexes have shown strong potential for drug-target affinity prediction. However, mos...

DOAJ Open Access (DOAJ) DOI: 10.1186/s12859-026-06481-5

A deep-reinforcement learning approach for optimizing homogeneous droplet routing in digital microfluidic biochips

Basudev Saha, Bidyut Das, Mukta Majumder • Nanotechnology and Precision Engineering (2023)

Over the past two decades, digital microfluidic biochips have been in much demand for safety-critical and biomedical applications and increasingly important in point-of-care analysis, drug discovery, and immunoassays, among other areas. How...

DOAJ Open Access (DOAJ) DOI: 10.1063/10.0017350

ACtriplet: An improved deep learning model for activity cliffs prediction by integrating triplet loss and pre-training

Xinxin Yu, Yimeng Wang, Long Chen, Weihua Li et al. • Journal of Pharmaceutical Analysis (2025)

Activity cliffs (ACs) are generally defined as pairs of similar compounds that only differ by a minor structural modification but exhibit a large difference in their binding affinity for a given target. ACs offer crucial insights that aid m...

DOAJ Open Access (DOAJ) DOI: 10.1016/j.jpha.2025.101317

The rise of deep learning in drug discovery

Hongming Chen, Ola Engkvist, Yinhai Wang, Marcus Olivecrona et al. • Drug Discovery Today (2018)

Over the past decade, deep learning has achieved remarkable success in various artificial intelligence research areas. Evolved from the previous research on artificial neural networks, this technology has shown superior performance to other...

OPENALEX cc-by DOI: https://doi.org/10.1016/j.drudis.2018.01.039

Deep Learning in Drug Discovery

Erik Gawehn, Jan A. Hiss, Gisbert Schneider • Molecular Informatics (2015)

Artificial neural networks had their first heyday in molecular informatics and drug discovery approximately two decades ago. Currently, we are witnessing renewed interest in adapting advanced neural network architectures for pharmaceutical ...

OPENALEX DOI: https://doi.org/10.1002/minf.201501008

Applications of Deep Learning in Biomedicine

Polina Mamoshina, Armando S. Vieira, Eugene Lane, Alex A. Zhavoronkov • Molecular Pharmaceutics (2016)

Increases in throughput and installed base of biomedical research equipment led to a massive accumulation of -omics data known to be highly variable, high-dimensional, and sourced from multiple often incompatible data platforms. While this ...

OPENALEX DOI: https://doi.org/10.1021/acs.molpharmaceut.5b00982

Machine learning in pain research

Jörn Lötsch, Alfred Ultsch • Pain (2017)

1. Introduction Pain and pain chronification are incompletely understood and unresolved medical problems that continue to have a high prevalence.14 It has been accepted that pain is a complex phenomenon.2,32,72 Contemporary methods of compu...

OPENALEX cc-by-nc-nd DOI: https://doi.org/10.1097/j.pain.0000000000001118 PMC: 5895117